Abreo F - Search Results

1

Chemokine receptor CXCR4 overexpression predicts recurrence for hormone receptor-positive, node-negative breast cancer patients.

Chu QD, Holm NT, Madumere P, Johnson LW, Abreo F, Li BD. Chu QD, et al. Among authors: abreo f. Surgery. 2011 Feb;149(2):193-9. doi: 10.1016/j.surg.2010.05.016. Surgery. 2011. PMID: 20598333

2

A prospective trial on initiation factor 4E (eIF4E) overexpression and cancer recurrence in node-positive breast cancer.

McClusky DR, Chu Q, Yu H, Debenedetti A, Johnson LW, Meschonat C, Turnage R, McDonald JC, Abreo F, Li BD. McClusky DR, et al. Among authors: abreo f. Ann Surg. 2005 Oct;242(4):584-90; discussion 590-2. doi: 10.1097/01.sla.0000184224.55949.90. Ann Surg. 2005. PMID: 16192819 Free PMC article. Clinical Trial.

3

High eIF4E, VEGF, and microvessel density in stage I to III breast cancer.

Byrnes K, White S, Chu Q, Meschonat C, Yu H, Johnson LW, Debenedetti A, Abreo F, Turnage RH, McDonald JC, Li BD. Byrnes K, et al. Among authors: abreo f. Ann Surg. 2006 May;243(5):684-90; discussion 691-2. doi: 10.1097/01.sla.0000216770.23642.d8. Ann Surg. 2006. PMID: 16633004 Free PMC article.

4

Correlation of TLK1B in elevation and recurrence in doxorubicin-treated breast cancer patients with high eIF4E overexpression.

Byrnes KW, DeBenedetti A, Holm NT, Luke J, Nunez J, Chu QD, Meschonat C, Abreo F, Johnson LW, Li BD. Byrnes KW, et al. Among authors: abreo f. J Am Coll Surg. 2007 May;204(5):925-33; discussion 933-4. doi: 10.1016/j.jamcollsurg.2007.02.027. J Am Coll Surg. 2007. PMID: 17481512

5

Elevated levels of chemokine receptor CXCR4 in HER-2 negative breast cancer specimens predict recurrence.

Holm NT, Byrnes K, Li BD, Turnage RH, Abreo F, Mathis JM, Chu QD. Holm NT, et al. Among authors: abreo f. J Surg Res. 2007 Jul;141(1):53-9. doi: 10.1016/j.jss.2007.03.015. J Surg Res. 2007. PMID: 17574038

6

Elevated chemokine receptor CXCR4 expression in primary tumors following neoadjuvant chemotherapy predicts poor outcomes for patients with locally advanced breast cancer (LABC).

Holm NT, Abreo F, Johnson LW, Li BD, Chu QD. Holm NT, et al. Among authors: abreo f. Breast Cancer Res Treat. 2009 Jan;113(2):293-9. doi: 10.1007/s10549-008-9921-8. Epub 2008 Feb 13. Breast Cancer Res Treat. 2009. PMID: 18270814 Clinical Trial.

7

A prospective trial on initiation factor 4E (eIF4E) overexpression and cancer recurrence in node-negative breast cancer.

Holm N, Byrnes K, Johnson L, Abreo F, Sehon K, Alley J, Meschonat C, Md QC, Li BD. Holm N, et al. Among authors: abreo f. Ann Surg Oncol. 2008 Nov;15(11):3207-15. doi: 10.1245/s10434-008-0086-9. Epub 2008 Aug 22. Ann Surg Oncol. 2008. PMID: 18719964

8

Trimodal therapy for inflammatory breast cancer: a surgeon's perspective.

Li BD, Sicard MA, Ampil F, Abreo F, Lilien D, Chu QD, Burton GV. Li BD, et al. Among authors: abreo f. Oncology. 2010;79(1-2):3-12. doi: 10.1159/000318529. Epub 2010 Nov 3. Oncology. 2010. PMID: 21051912 Review.

9

Prospective study of eukaryotic initiation factor 4E protein elevation and breast cancer outcome.

Li BD, Gruner JS, Abreo F, Johnson LW, Yu H, Nawas S, McDonald JC, DeBenedetti A. Li BD, et al. Among authors: abreo f. Ann Surg. 2002 May;235(5):732-8; discussion 738-9. doi: 10.1097/00000658-200205000-00016. Ann Surg. 2002. PMID: 11981220 Free PMC article.

10

Cystatin m: a novel candidate tumor suppressor gene for breast cancer.

Zhang J, Shridhar R, Dai Q, Song J, Barlow SC, Yin L, Sloane BF, Miller FR, Meschonat C, Li BD, Abreo F, Keppler D. Zhang J, et al. Among authors: abreo f. Cancer Res. 2004 Oct 1;64(19):6957-64. doi: 10.1158/0008-5472.CAN-04-0819. Cancer Res. 2004. PMID: 15466187

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

95 results

Search Page